Area of research
Molecular Biology · Physiology
Research interest
Research interests include Nivolumab, Biology, Medicine, Ipilimumab, Transcriptome, and Immune checkpoint.
Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial
G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab